Infusion Pumps
Publication Date
February 2024
USD 18.03 billion
USD 29.36 billion
USD 19.25 billion
Infusion Pumps Market by Product (Ambulatory Infusion Pump, Enteral Infusion Pump, Implantable Infusion Pump), Mode (Portable Infusion Pump, Stationary Infusion Pump), Operation, Application, End User - Global Forecast 2024-2030

[197 Pages Report] The Infusion Pumps Market size was estimated at USD 18.03 billion in 2023 and expected to reach USD 19.25 billion in 2024, at a CAGR 7.21% to reach USD 29.36 billion by 2030.

Infusion Pumps Market
To learn more about this report, request a free sample copy

An infusion pump is a medical device used to deliver fluids, such as medications, nutrients, or liquids for hydration, into a patient’s body in a controlled and precise manner. These pumps are designed to administer liquids in controlled amounts over specific periods, ensuring accurate dosing and continuous delivery as required by the patient’s treatment plan. Infusion pumps are commonly used in hospitals, homecare settings, and clinics for delivering chemotherapy drugs, antibiotics, pain relievers, insulin, or other therapies requiring regulated administration. The increasing prevalence of chronic diseases and rising elderly population has established a significant need for infusion pumps for convenient delivery of medications. However, the occurrence of medication errors associated with infusion pumps, stringent regulatory requirements for product approval, and the high cost of infusion pump devices impede the development of infusion pumps. Market players are working on consistent R&D to improve the capabilities of infusion pumps while offering cost-effective products to address these limitations. Developing smart infusion pump systems with enhanced safety features and wireless connectivity presents additional opportunities for market expansion. Innovations such as integrating infusion pumps with electronic medical records (EMR), developing user-friendly interfaces, and smart alarms form opportunities for infusion pumps.

Infusion Pumps Market - Global Forecast 2024-2030
To learn more about this report, request a free sample copy
Product: Advancements to improve the performance of insulin pumps to improve disease outcomes for diabetic patients

An ambulatory infusion pump (AIP) is a small battery-powered pump that slowly delivers medicines such as chemotherapy or antibiotics into the patient's body. They are ideal for home care settings, allowing patients to move about while receiving medication. An enteral pump is designed to deliver liquid nutrients and medications to the patient's digestive tract. Implantable infusion pumps refer to pumps that are surgically placed under the skin to deliver long-term medication. They're mostly used in pain management and the treatment of spasticity. A battery powers the pump and connects to a tube or catheter placed in the appropriate body area. A patient-controlled analgesia (PCA) pump delivers pain medication and allows patients to self-administer a precisely controlled amount of medication as per the patient's requirements. An insulin pump is typically used to deliver insulin to diabetic patients and is used frequently at home. Syringe pumps are designed to deliver small volumes of medication at precise flow rates. They are paramount in neonatal care and critical care settings. Volumetric or large-volume pumps are used to deliver larger quantities of fluid to patients in a controlled manner. They are essential in various clinical settings for fluid replacement, blood transfusions, and delivering nutritional fluids.

Mode: Growing patient preference for portable infusion pumps due to innovations in homecare

Portable infusion pumps are compact and designed for patient mobility. They are highly preferred for homecare settings, ambulatory care, and during patient transportation. These devices benefit patients who require continuous medication, such as insulin or chemotherapy, without the constraint of staying immobile. Stationary infusion pumps are predominantly utilized in clinical settings, such as hospitals, where patients need constant care and monitoring. They provide bedside intravenous (IV) infusions for patients who require frequent bedside medication or nutrition. These pumps are typically more feature-rich and can handle more complex infusion therapies. Their need arises in situations that demand high precision and volume, such as in intensive care units or when multiple therapies are administered simultaneously.

Operation: Electrically operated infusion pumps offer greater control and monitoring capabilities

Electrically operated infusion pumps are widely used in healthcare settings for their precision and programmability. These infusion pumps are often preferred for continuous medication delivery, as they can ensure consistent flow rates. These pumps are particularly useful in critical care, neonatology, and oncology, where exact dosing is crucial. They are favored in hospitals and long-term care facilities for their ease of use and ability to administer complex dosing regimens. Mechanically operated infusion pumps are characterized by their simplicity and durability and do not rely on electrical power, which makes them ideal for use in areas with limited access to electricity or during transport situations. The preference for mechanically operated pumps is often driven by scenarios where portability and low maintenance are key considerations. These pumps are commonly used in home healthcare settings, ambulatory care, and developing regions. They provide a cost-effective solution for basic infusion needs and are appreciated for their reliability in delivering medication without electrical power.

Application: Need for infusion pumps with continuous glucose level monitoring and precise dose administration for diabetes patients

Chemotherapy infusion pumps are critical in the precise delivery of anti-cancer drugs. These devices need to ensure consistent and controlled administration, as chemotherapy agents can have narrow therapeutic windows and high toxicity. These pumps are often driven by the need for ambulatory options that allow patients to receive treatment without prolonged hospital stays. In managing diabetes, particularly Type 1, insulin infusion pumps play a vital role in maintaining blood glucose levels. The preference for these pumps stems from their ability to mimic the body's normal insulin release by delivering continuous subcutaneous insulin therapy. Infusion pumps used in gastroenterology are predominantly enteral pumps that deliver nutrients directly to patients' digestive tract when they cannot consume food orally. These pumps are favored for providing controlled and precise nutrition support. In hematology, infusion pumps are especially applicable for administering blood factors and medications for patients with blood disorders. Durable, reliable, and programmable infusion pumps are preferred in this segment for various treatments, including immunoglobin therapy. Pain management applications necessitate infusion pumps that can deliver analgesics accurately, typically in post-operative settings or for chronic pain conditions. Patients and healthcare providers prefer portable, programmable, and easy-to-use pumps. Pediatric infusion pumps must be extremely precise due to the small amounts of medication required for children and neonates. Chemotherapy and hematology demand pumps with high precision and safety profiles due to the toxic nature of treatments. Diabetes care prioritizes continuous infusion and glucose monitoring integrations, while pain management seeks portability and programmability. Gastroenterology requires robust enteral pumps, and pediatrics necessitates extreme precision and safety.

End-User: Adoption of highly-reliable and safe infusion pumps that cater to multiple disease cases in hospitals

Academic & research institutes typically require infusion pumps for experimental and educational purposes. These institutes prioritize precision, programmability, and advanced data tracking capabilities to facilitate detailed research studies and experiments. Pumps in this setting are often integrated with other laboratory equipment for more streamlined data gathering. Ambulatory care settings value portable and user-friendly infusion pumps that ensure continuous care without the constraints of a stationary setup, and outpatient clinics, mobile care units, and day surgery centers fall under this category. The need for compactness, battery life, and ease of use of infusion pumps are critical factors in this setting. Home care settings have seen a rise in the demand for infusion pumps as more patients prefer in-home treatments. These pumps are used for chronic disease management, palliative care, and nutrition support, among others. Hospitals are the largest consumer of infusion pumps, requiring a wide range of devices to cater to various departments, such as anesthesiology, oncology, pediatrics, and intensive care units. Hospitals often prioritize reliability, interoperability with hospital information systems, high throughput, and advanced safety features in infusion pumps.

Regional Insights

The Americas region is characterized by a robust healthcare infrastructure, high government healthcare spending, and several key players, thereby driving the region's growth and demand for infusion pumps. The region is also involved in constant product innovations, and regulatory bodies such as the Food and Drug Administration (FDA) frequently streamline medical device approvals for infusion pumps. Furthermore, technological innovations have fuelled the integration of smart technologies and wireless monitoring in infusion devices. EU countries benefit from high healthcare standards and stringent regulations that ensure the quality and safety of infusion devices. Collaborations amongst member states and substantial investment in healthcare technology drive research and development for infusion pumps in the EU. The EU also experiences a rising demand for personalized medicine and home infusion therapy. The Asia-Pacific region is experiencing rapid market growth due to rising healthcare expenditures and increasing awareness of advanced therapeutic options. Countries such as China, Japan, and India contribute to the region's expansion. In China, government initiatives to modernize healthcare and expand rural access have bolstered the market growth.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Infusion Pumps Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Infusion Pumps Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Fresenius Kabi, Mayo Clinic ink Deal On Ivenix Infusion System

    Fresenius Kabi has joined forces with the esteemed Mayo Clinic to implement the innovative Ivenix Infusion System. This state-of-the-art technology promises to revolutionize the infusion pump market by offering advanced safety features and an intuitive user interface to minimize medication errors and enhance patient care. The partnership highlights a collaborative commitment to clinical excellence, with the Ivenix system as a critical component in facilitating effective, real-time infusion data integration into electronic medical records (EMRs), thus enabling healthcare professionals to deliver high-quality, efficient patient care. [Published On: 2023-12-15]

  • Tandem Diabetes Care Launches First Automated Insulin Pump Integrated With Dexcom G7 CGM

    Tandem Diabetes Care has announced the launch of an advanced automated insulin delivery system. This new offering, combined with the Dexcom G7 continuous glucose monitoring (CGM) system, embodies a landmark in precision medicine, providing diabetes patients with a more autonomous and personalized treatment solution. Leveraging cutting-edge algorithms, the system automates insulin delivery with heightened accuracy, enhancing the user's control over their glucose levels without constant manual adjustments. The union of Tandem's automated insulin pump with Dexcom's CGM system is emblematic of the strides being made in the field of diabetes care, where innovation is directly translating to improved quality of life for individuals living with this chronic illness. [Published On: 2023-12-06]

  • Monidor Expands Remote IV Therapy Monitoring in Collaboration with B. Braun

    Monidor has enhanced its market presence by partnering with B. Braun SE to advance remote IV therapy monitoring. Leveraging Monidor's expertise and B. Braun's extensive distribution network, this partnership aims to optimize infusion therapies and improve patient care. Integrating Monidor's Monidrop device and the MoniView software with B. Braun’s infusion systems facilitates accurate administration and oversight of IV fluids remotely, thus ensuring precise dosing and reducing the likelihood of manual errors. [Published On: 2023-08-29]

Key Company Profiles

The report delves into recent significant developments in the Infusion Pumps Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Avanos Medical, Inc., B. Braun SE, Baxter International Inc., Bayer AG, Becton, Dickinson and Company, Bio-x, Boston Scientific Corporation, Canadian Hospital Specialties Limited, Chemyx Inc., Epic Medical Pty Ltd., Fresenius Se & Co. KGaA, FUJIFILM Corporation, GE HealthCare Technologies Inc., ICU Medical, Inc., Insulet Corporation, Intera Oncology, Inc., Intuvie Holdings LLC, Ivenix, Inc., JMS Co., Ltd., Longer Precision Pump Co. Ltd. by Halma PLC, Medline Industries, LP, Medtronic PLC, Merck KGaA, Micrel Medical Devices SA, Moog Inc., Narang Medical Limited, New Era Pump Systems Inc., Nipro Corporation, Shenzhen MedRena Biotech Co., Ltd., SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD., Siemens AG, SOOIL Developments Co., Ltd., Tandem Diabetes Care, Inc., Teleflex Incorporated, Terumo Corporation, Thermo Fisher Scientific Inc., and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Infusion Pumps Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Ambulatory Infusion Pump
    • Enteral Infusion Pump
    • Implantable Infusion Pump
    • Insulin Pump
    • PCA Pump
    • Syringe Pump
    • Volumetric Pump
  • Mode
    • Portable Infusion Pump
    • Stationary Infusion Pump
  • Operation
    • Electrically Operated
    • Mechanically Operated
  • Application
    • Chemotherapy
    • Diabetes
    • Gastroenterology
    • Hematology
    • Pain Management
    • Pediatrics
  • End User
    • Academic & Research Institute
    • Ambulatory Care Setting
    • Home Care Setting
    • Hospital

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Infusion Pumps Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Infusion Pumps Market?
  3. What are the technology trends and regulatory frameworks in the Infusion Pumps Market?
  4. What is the market share of the leading vendors in the Infusion Pumps Market?
  5. Which modes and strategic moves are suitable for entering the Infusion Pumps Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Infusion Pumps Market, by Product
  7. Infusion Pumps Market, by Mode
  8. Infusion Pumps Market, by Operation
  9. Infusion Pumps Market, by Application
  10. Infusion Pumps Market, by End User
  11. Americas Infusion Pumps Market
  12. Asia-Pacific Infusion Pumps Market
  13. Europe, Middle East & Africa Infusion Pumps Market
  14. Competitive Landscape
  15. Competitive Portfolio
Companies Mentioned
  • 3M Company
  • Abbott Laboratories
  • Avanos Medical, Inc.
  • B. Braun SE
  • Baxter International Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • Bio-x
  • Boston Scientific Corporation
  • Canadian Hospital Specialties Limited
  • Chemyx Inc.
  • Epic Medical Pty Ltd.
  • Fresenius Se & Co. KGaA
  • FUJIFILM Corporation
  • GE HealthCare Technologies Inc.
  • ICU Medical, Inc.
  • Insulet Corporation
  • Intera Oncology, Inc.
  • Intuvie Holdings LLC
  • Ivenix, Inc.
  • JMS Co., Ltd.
  • Longer Precision Pump Co. Ltd. by Halma PLC
  • Medline Industries, LP
  • Medtronic PLC
  • Merck KGaA
  • Micrel Medical Devices SA
  • Moog Inc.
  • Narang Medical Limited
  • New Era Pump Systems Inc.
  • Nipro Corporation
  • Shenzhen MedRena Biotech Co., Ltd.
  • Siemens AG
  • SOOIL Developments Co., Ltd.
  • Tandem Diabetes Care, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
  • Ypsomed AG
This FREE sample includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.
Frequently Asked Questions about the Infusion Pumps Market
The Global Infusion Pumps Market size was estimated at USD 18.03 billion in 2023 and expected to reach USD 19.25 billion in 2024.
The Global Infusion Pumps Market to grow USD 29.36 billion by 2030, at a CAGR of 7.21%
Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
We are approaching our 7th anniversary in 2024!
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
Absolutely yes, with the purchase of additional user licenses.
Absolutely yes, so long as the 360iResearch cited correctly.